; (B) avoid inappropriate prescribing that can lead to dangerous drug interactions, overdose, or relapse; and (C) notify and involve families and caregivers when individuals experience an overdose. (3) Periodic updates The Secretary shall— (A) periodically review and update the model programs and materials identified or developed under paragraph (1); and (B) disseminate such updated programs and materials to the individuals described in paragraph (1)(A). (4) Input of certain entities In identifying, reviewing, or updating the model programs and materials under this subsection, the Secretary shall solicit the input of relevant stakeholders. (l) Rules of construction Nothing in this Act or the amendments made by this Act shall be construed to limit— (1) a patient’s right, as described in section 164.522 of title 45, Code of Federal Regulations, or any successor regulation, to request a restriction on the use or disclosure of a record referred to in section 543(a) of the Public Health Service Act ( 42 U.S.C. 290dd–2(a) ) for purposes of treatment, payment, or health care operations; or (2) a covered entity’s choice, as described in section 164.506 of title 45, Code of Federal Regulations, or any successor regulation, to obtain the consent of the individual to use or disclose a record referred to in such section 543(a) to carry out treatment, payment, or health care operation. (m) Sense of Congress It is the sense of the Congress that— (1) patients have the right to request a restriction on the use or disclosure of a record referred to in section 543(a) of the Public Health Service Act ( 42 U.S.C. 290dd–2(a) ) for treatment, payment, or health care operations; and (2) covered entities should make every reasonable effort to the extent feasible to comply with a patient’s request for a restriction regarding such use or disclosure.